[HTML][HTML] Bortezomib-induced epigenetic alterations in nerve cells: focus on the mechanisms contributing to the peripheral neuropathy development
K Łuczkowska, D Rogińska, P Kulig… - International Journal of …, 2022 - mdpi.com
Bortezomib-induced peripheral neuropathy (BiPN) occurs in approximately 40% of patients
with multiple myeloma. The induction of severe neuropathy entails the dose reduction or …
with multiple myeloma. The induction of severe neuropathy entails the dose reduction or …
Bortezomib-Induced Epigenetic Alterations in Nerve Cells: Focus on the Mechanisms Contributing to the Peripheral Neuropathy Development
K Łuczkowska, D Rogińska, P Kulig… - International …, 2022 - pubmed.ncbi.nlm.nih.gov
Bortezomib-induced peripheral neuropathy (BiPN) occurs in approximately 40% of patients
with multiple myeloma. The induction of severe neuropathy entails the dose reduction or …
with multiple myeloma. The induction of severe neuropathy entails the dose reduction or …
Bortezomib-Induced Epigenetic Alterations in Nerve Cells: Focus on the Mechanisms Contributing to the Peripheral Neuropathy Development
K Łuczkowska, D Rogińska, P Kulig, A Bielikowicz… - agris.fao.org
Bortezomib-induced peripheral neuropathy (BiPN) occurs in approximately 40% of patients
with multiple myeloma. The induction of severe neuropathy entails the dose reduction or …
with multiple myeloma. The induction of severe neuropathy entails the dose reduction or …
[PDF][PDF] Rogi nska
K Łuczkowska - Int. J. Mol. Sci, 2022 - researchgate.net
Bortezomib-induced peripheral neuropathy (BiPN) occurs in approximately 40% of patients
with multiple myeloma. The induction of severe neuropathy entails the dose reduction or …
with multiple myeloma. The induction of severe neuropathy entails the dose reduction or …
Bortezomib-Induced Epigenetic Alterations in Nerve Cells: Focus on the Mechanisms Contributing to the Peripheral Neuropathy Development.
K Łuczkowska, D Rogińska, P Kulig… - … Journal of Molecular …, 2022 - europepmc.org
Bortezomib-induced peripheral neuropathy (BiPN) occurs in approximately 40% of patients
with multiple myeloma. The induction of severe neuropathy entails the dose reduction or …
with multiple myeloma. The induction of severe neuropathy entails the dose reduction or …
Bortezomib-Induced Epigenetic Alterations in Nerve Cells: Focus on the Mechanisms Contributing to the Peripheral Neuropathy Development
K Łuczkowska, D Rogińska, P Kulig… - International …, 2022 - search.proquest.com
Bortezomib-induced peripheral neuropathy (BiPN) occurs in approximately 40% of patients
with multiple myeloma. The induction of severe neuropathy entails the dose reduction or …
with multiple myeloma. The induction of severe neuropathy entails the dose reduction or …
[HTML][HTML] Bortezomib-Induced Epigenetic Alterations in Nerve Cells: Focus on the Mechanisms Contributing to the Peripheral Neuropathy Development
K Łuczkowska, D Rogińska, P Kulig… - … Journal of Molecular …, 2022 - ncbi.nlm.nih.gov
Bortezomib-induced peripheral neuropathy (BiPN) occurs in approximately 40% of patients
with multiple myeloma. The induction of severe neuropathy entails the dose reduction or …
with multiple myeloma. The induction of severe neuropathy entails the dose reduction or …
Bortezomib-Induced Epigenetic Alterations in Nerve Cells: Focus on the Mechanisms Contributing to the Peripheral Neuropathy Development.
K Łuczkowska, D Rogińska, P Kulig… - International …, 2022 - search.ebscohost.com
Bortezomib-induced peripheral neuropathy (BiPN) occurs in approximately 40% of patients
with multiple myeloma. The induction of severe neuropathy entails the dose reduction or …
with multiple myeloma. The induction of severe neuropathy entails the dose reduction or …
Bortezomib-Induced Epigenetic Alterations in Nerve Cells: Focus on the Mechanisms Contributing to the Peripheral Neuropathy Development.
K Łuczkowska, D Rogińska, P Kulig… - … Journal of Molecular …, 2022 - europepmc.org
Bortezomib-induced peripheral neuropathy (BiPN) occurs in approximately 40% of patients
with multiple myeloma. The induction of severe neuropathy entails the dose reduction or …
with multiple myeloma. The induction of severe neuropathy entails the dose reduction or …